Get the Stockscreener App
5.40
0.93%
0.05
After Hours:
5.46
0.06
+1.11%
Immatics N V stock is traded at $5.40, with a volume of 1.64M.
It is up +0.93% in the last 24 hours and down -21.17% over the past month.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
See More
Previous Close:
$5.35
Open:
$5.5
24h Volume:
1.64M
Relative Volume:
2.48
Market Cap:
$656.37M
Revenue:
$58.49M
Net Income/Loss:
$-105.04M
P/E Ratio:
-4.1548
EPS:
-1.2997
Net Cash Flow:
$-13.78M
1W Performance:
-9.55%
1M Performance:
-21.17%
6M Performance:
-56.87%
1Y Performance:
-52.84%
1-Day Range:
$5.34
$5.535
1-Week Range:
$5.28
$6.32
52-Week Range:
$5.28
$13.77
Immatics N V Stock (IMTX) Company Profile
Compare IMTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
5.40 | 656.37M | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
Is Immatics N.V. (IMTX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey
Immatics (NASDAQ:IMTX) Short Interest Up 13.1% in December - MarketBeat
Immatics (NASDAQ:IMTX) Shares Sold by JPMorgan Chase & Co. - Defense World
Immatics (NASDAQ:IMTX) Reaches New 52-Week LowTime to Sell? - MarketBeat
Immatics (NASDAQ:IMTX) Shares Down 3.9%What's Next? - MarketBeat
Down -16.85% in 4 Weeks, Here's Why Immatics (IMTX) Looks Ripe for a Turnaround - Yahoo Finance
Revenues Working Against Immatics N.V.'s (NASDAQ:IMTX) Share Price - Simply Wall St
Immatics N.V.: Considering More Engineered T Cells For Cancer (NASDAQ:IMTX) - Seeking Alpha
Immatics (NASDAQ:IMTX) Hits New 52-Week LowShould You Sell? - MarketBeat
IMTX: 3 Small-Cap Healthcare Stocks With Big Upside Potential - StockNews.com
Analyzing Immatics (NASDAQ:IMTX) & Kyverna Therapeutics (NASDAQ:KYTX) - Defense World
Immatics (IMTX) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
How to Take Advantage of moves in (IMTX) - Stock Traders Daily
State Street Corp Grows Position in Immatics (NASDAQ:IMTX) - Defense World
Immatics (NASDAQ:IMTX) & Achilles Therapeutics (NASDAQ:ACHL) Financial Survey - Defense World
ZTS: 3 Healthcare Innovators with Analyst-Endorsed Upside - StockNews.com
(IMTX) Technical Data - Stock Traders Daily
Immatics (NASDAQ:IMTXW) Stock Price Down 0.7% – Time to Sell? - Defense World
Comparing Calidi Biotherapeutics (NYSE:CLDI) & Immatics (NASDAQ:IMTX) - Defense World
Immatics (NASDAQ:IMTX) Hits New 12-Month LowWhat's Next? - MarketBeat
Immatics (NASDAQ:IMTX) Sees Significant Increase in Short Interest - MarketBeat
(IMTX) Technical Pivots with Risk Controls - Stock Traders Daily
Immatics (NASDAQ:IMTX) Trading Down 4.2%What's Next? - MarketBeat
Immatics Faces Termination of Key Collaboration with Bristol Myers Squibb - TipRanks
Immatics (NASDAQ:IMTX) Shares Bought by Frazier Life Sciences Management L.P. - MarketBeat
Wellington Management Group LLP Has $110.46 Million Stock Holdings in Immatics (NASDAQ:IMTX) - MarketBeat
The Manufacturers Life Insurance Company Grows Stock Position in Immatics (NASDAQ:IMTX) - Defense World
Reviewing bluebird bio (NASDAQ:BLUE) and Immatics (NASDAQ:IMTX) - Defense World
Why Is Immatics N.V. (IMTX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Yahoo Finance
Walleye Capital LLC Lowers Stock Holdings in Immatics (NASDAQ:IMTX) - MarketBeat
Braidwell LP Makes New $18.80 Million Investment in Immatics (NASDAQ:IMTX) - MarketBeat
Immatics NV (FRA:4A3) EBITDA per Share : €-0.40 (TTM As of Sep. 2024) - GuruFocus.com
Vestal Point Capital LP Grows Stock Holdings in Immatics (NASDAQ:IMTX) - MarketBeat
Immatics (NASDAQ:IMTX) Upgraded by The Goldman Sachs Group to "Strong-Buy" Rating - MarketBeat
Exscientia (NASDAQ:EXAI) & Immatics (NASDAQ:IMTX) Head to Head Comparison - Defense World
Immatics N.V. Reports Strong Q3 2024 Progress and Financials - TipRanks
(IMTX) Investment Analysis - Stock Traders Daily
Cantor Fitzgerald Raises Earnings Estimates for Immatics - Defense World
Immatics FY2024 EPS Forecast Boosted by Cantor Fitzgerald - MarketBeat
Analysts Set Expectations for Immatics FY2024 Earnings - Defense World
FY2024 EPS Estimates for Immatics Increased by Analyst - MarketBeat
Immatics (NASDAQ:IMTX) Reaches New 1-Year Low Following Analyst Downgrade - Defense World
Bank of America Has Lowered Expectations for Immatics (NASDAQ:IMTX) Stock Price - Defense World
Immatics N.V. (NASDAQ:IMTX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Yahoo Finance
10 Best German Stocks To Buy Now - Insider Monkey
Is Immatics N.V. (IMTX) the Best German Stock to Buy Now? - Insider Monkey
Bank of America Issues Pessimistic Forecast for Immatics (NASDAQ:IMTX) Stock Price - MarketBeat
Immatics Sees Revenue Surge Despite R&D Expenses - Yahoo Finance
Immatics: Q3 Earnings Snapshot - Milford Mirror
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):